EP Patent

EP1690532A1 — Device for gastric treatment and manufacturing process for the same

Assigned to Nolabs AB · Expires 2006-08-16 · 20y expired

What this patent protects

A device is provided that allows for target treatment of gastric and gastrointestinal complications, including gastric ulcer. The device comprises a nitric oxide (NO) eluting polymer arranged to contact the area to be treated, such that a therapeutic dose of nitric oxide is elute…

USPTO Abstract

A device is provided that allows for target treatment of gastric and gastrointestinal complications, including gastric ulcer. The device comprises a nitric oxide (NO) eluting polymer arranged to contact the area to be treated, such that a therapeutic dose of nitric oxide is eluted from said nitric oxide eluting polymer to said area. Furthermore, a manufacturing method for said device is disclosed.

Drugs covered by this patent

Patent Metadata

Patent number
EP1690532A1
Jurisdiction
EP
Classification
—
Expires
2006-08-16
Drug substance claim
No
Drug product claim
No
Assignee
Nolabs AB
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.